UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Optimizing treatment duration with ramucirumab and paclitaxel by managing chemotherapy-associated toxicity: Review of four cases

SAGE open medical case reports, 2020-10, Vol.8, p.2050313

2020

Volltextzugriff (PDF)

The impact of corticosteroid use during anti-PD1 treatment

Journal of oncology pharmacy practice, 2020-06, Vol.26 (4), p.814-822

2020

Volltextzugriff (PDF)

Opportunities for pharmacists to integrate pharmacogenomics into clinical practice

The pharmacogenomics journal, 2020-04, Vol.20 (2), p.169-178

2020

Volltextzugriff (PDF)

Assessment of extended urine protein monitoring frequency in patients receiving bevacizumab

Journal of oncology pharmacy practice, 2021-06, Vol.27 (4), p.902-906

2021

Volltextzugriff (PDF)

Fidaxomicin versus Conventional Antimicrobial Therapy in 59 Recipients of Solid Organ and Hematopoietic Stem Cell Transplantation with Clostridium difficile-Associated Diarrhea

Antimicrobial Agents and Chemotherapy, 2013-09, Vol.57 (9), p.4501-4505

2013

Volltextzugriff (PDF)

Combining integrated genomics and functional genomics to dissect the biology of a cancer-associated, aberrant transcription factor, the ASPSCR1-TFE3 fusion oncoprotein

The Journal of pathology, 2013-04, Vol.229 (5), p.743-754

2013

Volltextzugriff (PDF)

Association of Hospitalist Care and Outcomes on an Inpatient Elective Anticancer Therapy Service

Blood, 2023-11, Vol.142 (Supplement 1), p.2335-2335

2023

Volltextzugriff (PDF)

Real-World Incidence of Pneumonitis in Patients Receiving Durvalumab

Clinical lung cancer, 2022-01, Vol.23 (1), p.34-42

2022

Volltextzugriff (PDF)

Outcomes With Combination Pembrolizumab and Axitinib in Second and Further Line Treatment of Metastatic Renal Cell Carcinoma

Clinical genitourinary cancer, 2023-04, Vol.21 (2), p.221-229

2023

Volltextzugriff (PDF)

Feasibility and Safety of Outpatient Hypomethylating Agent (HMA) + Venetoclax (Ven) Initiation +/- Ramp-up for Patients (pts) with Newly-Diagnosed Acute Myeloid Leukemia (AML)

Blood, 2022-11, Vol.140 (Supplement 1), p.8921-8922

2022

Volltextzugriff (PDF)

The Use of Oral Anticoagulants for the Treatment of Venous Thromboembolism in Cancer Patients

Blood, 2015-12, Vol.126 (23), p.4728-4728

2015

Volltextzugriff (PDF)

Association of Hospitalist Care and Outcomes for Patients Electively Admitted for Chemotherapy

Journal of Brown Hospital Medicine, 2024-04, Vol.3 (2)

2024

Volltextzugriff (PDF)

Arformoterol: The first nebulized long-acting beta^sub 2^-adrenergic agonist

Formulary (Cleveland, Ohio), 2007-02, Vol.42 (2), p.99

2007

Volltextzugriff (PDF)

Arformoterol: the first nebulized long-acting -adrenergic agonist

Formulary (Cleveland, Ohio), 2007-02, Vol.42 (2), p.99

2007

Volltextzugriff (PDF)

Updates of adjuvant therapy in pancreatic cancer: where are we and where are we going? Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010

Journal of the Pancreas, 2010-07, Vol.11 (4), p.310-312

2010

Volltextzugriff (PDF)

First-line treatment of metastatic pancreatic adenocarcinoma: can we do better? Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010

Journal of the Pancreas, 2010-07, Vol.11 (4), p.317-320

2010

Volltextzugriff (PDF)

Any second-line therapy for advanced pancreatic cancer? Highlights from the "2010 ASCO Gastrointestinal Cancers Symposium". Orlando, FL, USA. January 22-24, 2010

Journal of the Pancreas, 2010-03, Vol.11 (2), p.151-153

2010

Volltextzugriff (PDF)

The first-line treatment for advanced pancreatic cancer. Highlights from the "2010 ASCO Gastrointestinal Cancers Symposium". Orlando, FL, USA. January 22-24, 2010

Journal of the Pancreas, 2010-03, Vol.11 (2), p.148-150

2010

Volltextzugriff (PDF)

Effect of nesiritide on renal function: a retrospective review

Current medical research and opinion, 2005-11, Vol.21 (11), p.1857-1863

2005

Volltextzugriff (PDF)

Effect of nesiritide on renal function: a retrospective review

Current Medical Research and Opinion, 2005, Vol.21 (11), p.1857-1863

2005

Volltextzugriff (PDF)

Antifungal Consideration for Transplant Recipients

Principles and Practice of Transplant Infectious Diseases, p.927-940

Volltextzugriff (PDF)

1 – 21 von 21

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(14)
Mit Volltextzugriff
(19)

Publikationsform

Sprache

Englisch
(21)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Humans
(10)
Life Sciences & Biomedicine
(9)
Science & Technology
(9)
Oncology
(5)
Congresses As Topic
(4)
Immunotherapy
(4)
Pharmacology & Pharmacy
(4)
Aged
(3)
Drug Therapy
(3)
Female
(3)
Male
(3)
Retrospective Studies
(3)
United States
(3)
Adult
(2)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(2)
Carcinoma - Drug Therapy
(2)
Chicago
(2)
Combined Modality Therapy
(2)
Decompensated Heart Failure
(2)
Disease Progression
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Optimizing treatment duration with ramucirumab and paclitaxel by managing chemotherapy-associated toxicity: Review of four cases

The impact of corticosteroid use during anti-PD1 treatment

Opportunities for pharmacists to integrate pharmacogenomics into clinical practice

Assessment of extended urine protein monitoring frequency in patients receiving bevacizumab

Fidaxomicin versus Conventional Antimicrobial Therapy in 59 Recipients of Solid Organ and Hematopoietic Stem Cell Transplantation with Clostridium difficile-Associated Diarrhea

Combining integrated genomics and functional genomics to dissect the biology of a cancer-associated, aberrant transcription factor, the ASPSCR1-TFE3 fusion oncoprotein

Association of Hospitalist Care and Outcomes on an Inpatient Elective Anticancer Therapy Service

Real-World Incidence of Pneumonitis in Patients Receiving Durvalumab

Outcomes With Combination Pembrolizumab and Axitinib in Second and Further Line Treatment of Metastatic Renal Cell Carcinoma

Feasibility and Safety of Outpatient Hypomethylating Agent (HMA) + Venetoclax (Ven) Initiation +/- Ramp-up for Patients (pts) with Newly-Diagnosed Acute Myeloid Leukemia (AML)

The Use of Oral Anticoagulants for the Treatment of Venous Thromboembolism in Cancer Patients

Association of Hospitalist Care and Outcomes for Patients Electively Admitted for Chemotherapy

Arformoterol: The first nebulized long-acting beta^sub 2^-adrenergic agonist

Arformoterol: the first nebulized long-acting -adrenergic agonist

Updates of adjuvant therapy in pancreatic cancer: where are we and where are we going? Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010

First-line treatment of metastatic pancreatic adenocarcinoma: can we do better? Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010

Any second-line therapy for advanced pancreatic cancer? Highlights from the "2010 ASCO Gastrointestinal Cancers Symposium". Orlando, FL, USA. January 22-24, 2010

The first-line treatment for advanced pancreatic cancer. Highlights from the "2010 ASCO Gastrointestinal Cancers Symposium". Orlando, FL, USA. January 22-24, 2010

Effect of nesiritide on renal function: a retrospective review

Effect of nesiritide on renal function: a retrospective review

Antifungal Consideration for Transplant Recipients

Suchergebnisse filtern